Cardiotoxicity of methamphetamine under stress conditions: Comparison of single dose and long-term use

Tomita,Masafumi; Okuyama,Toshiko; Katsuyama,Hironobu; Watanabe,Yoko; Shinone,Kotaro; Nata,Masayuki; Ishikawa,Takaki

doi:10.3892/mmr.2013.1408

Cardiotoxicity of methamphetamine under stress conditions: Comparison of single dose and long-term use

Authors:
- Masafumi Tomita
- Toshiko Okuyama
- Hironobu Katsuyama
- Yoko Watanabe
- Kotaro Shinone
- Masayuki Nata
- Takaki Ishikawa
View Affiliations

Affiliations: Department of Medical Toxicology, Kawasaki Medical School, Kurashiki 701‑0192, Japan, Department of Public Health, Kawasaki Medical School, Kurashiki 701‑0192, Japan, Department of Natural Sciences, Kawasaki Medical School, Kurashiki 701‑0192, Japan, Department of Forensic Medicine and Sciences, Mie University School of Medicine, Tsu 514‑8507, Japan, Department of Legal Medicine, Osaka City University Medical School, Osaka 545‑8585, Japan
Published online on: April 2, 2013 https://doi.org/10.3892/mmr.2013.1408
Pages: 1786-1790

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Methamphetamine (METH) abuse continues to be a worldwide problem, damaging the myocardial tissues, as well as the brains of individual users. In addition, stressors that increase drug cravings also contribute to cardiovascular diseases. The aim of the present study was to examine the myocardial effects of METH, including METH‑stress interactions and particularly, the effect of METH RNA expression in the heart. The study also aimed to compare single dose (acute) and long-term (chronic) treatments. Mice were divided into the control (C), METH injection (M), stress exposure (S) and METH plus stress (MS) groups and subjected to an acute water‑immersion restraint stress or a mixed chronic stress composed of restraint, electric foot‑shock and temperature change. METH was injected at 30 mg/kg (the acute study) or 10 mg/kg intraperitoneally (i.p.) three times per week (the chronic study). The results demonstrated that METH induced more deleterious effects in the myocardial tissues during acute and chronic administrations when under stress conditions. Heat shock proteins (Hsps) played a critical role in the acute phase, while numerous genes, including anti‑oxidant, anti‑apoptotic and physiological function genes, played significant roles in the chronic phase. These results indicate that METH abuse, ranging from episodes of binge abuse to chronic abuse over several years, may cause severe myocardial damage in human users under stress.

View Figures

View References

1	Brecht ML, von Mayrhauser C and Anglin MD: Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs. 32:211–220. 2000. View Article : Google Scholar : PubMed/NCBI
2	Comer SD, Hart CL, Ward AS, Haney M, Foltin RW and Fischman MW: Effects of repeated oral methamphetamine administration in humans. Psychopharmacology (Berl). 155:397–404. 2001. View Article : Google Scholar : PubMed/NCBI
3	Wada K: The history and current state of drug abuse in Japan. Ann NY Acad Sci. 1216:62–72. 2011. View Article : Google Scholar : PubMed/NCBI
4	Saito T, Takeichi S, Nakajima Y, Yukawa N and Osawa M: Fatal methamphetamine poisoning in police custody. J Clin Forensic Med. 3:183–185. 1996. View Article : Google Scholar : PubMed/NCBI
5	Inoue H, Ikeda N, Kudo K, Ishida T, Terada M and Matoba R: Methamphetamine-related sudden death with a concentration which was of a ‘toxic level’. Leg Med (Tokyo). 8:150–155. 2006.
6	Wijetunga M, Seto T, Lindsay J and Schatz I: Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 41:981–986. 2003. View Article : Google Scholar : PubMed/NCBI
7	Tsigos C and Chrousos GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 53:865–871. 2002. View Article : Google Scholar : PubMed/NCBI
8	Miller GE, Chen E and Zhou ES: If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 133:25–45. 2007. View Article : Google Scholar : PubMed/NCBI
9	Kishi T: Heart failure as an autonomic nervous system dysfunction. J Cardiology. 59:117–122. 2012. View Article : Google Scholar : PubMed/NCBI
10	Pickering TG: Does psychological stress contribute to the development of hypertension and coronary heart disease? Eur J Clin Pharmacol. 39(Suppl 1): S1–S7. 1990. View Article : Google Scholar : PubMed/NCBI
11	Tidey JW and Miczek KA: Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology (Berl). 130:203–212. 1997. View Article : Google Scholar : PubMed/NCBI
12	Piazza PV and Le Moal M: The role of stress in drug self-administration. Trends Pharmacol Sci. 19:67–74. 1998. View Article : Google Scholar : PubMed/NCBI
13	Perkins KA and Grobe JE: Increased desire to smoke during acute stress. Br J Addict. 87:1037–1040. 1992. View Article : Google Scholar : PubMed/NCBI
14	Sinha R: How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl). 158:343–359. 2001. View Article : Google Scholar : PubMed/NCBI
15	Sinha R, Catapano D and O’Malley S: Stress-induced craving and stress response in cocaine dependent individuals. Psycho- pharmacology (Berl). 142:343–351. 1999. View Article : Google Scholar : PubMed/NCBI
16	Zhao LY, Shi J, Zhang XL and Lu L: Psychosocial stress enhances non-drug-related positive memory retrieval in male abstinent heroin addicts. Neurosci Lett. 485:16–20. 2010. View Article : Google Scholar : PubMed/NCBI
17	Söderpalm AH, Nikolayev L and de Wit H: Effects of stress on responses to methamphetamine in humans. Psychopharmacology (Berl). 170:188–199. 2003.PubMed/NCBI
18	Stratton SJ, Rogers C, Brickett K and Gruzinski G: Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med. 19:187–191. 2001. View Article : Google Scholar : PubMed/NCBI
19	Uemura K, Ueyama T, Shintani-Ishida K, Unuma K and Yoshida K: An autopsy report on four sudden cardiac death cases by immobilization. Int Med J. 15:301–305. 2008.
20	Tomita M, Katsuyama H, Watanabe Y, et al: Water-restraint stress enhances methamphetamine-induced cardiotoxicity. Chem Biol Interact. 190:54–61. 2011. View Article : Google Scholar : PubMed/NCBI
21	Ikeda U, Ohkawa F, Seino Y, et al: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol. 24:579–84. 1992. View Article : Google Scholar : PubMed/NCBI
22	Jirik FR, Podor TJ, Hirano T, et al: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 142:144–147. 1989.PubMed/NCBI
23	Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J and Kishimoto T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1520–1524. 1995. View Article : Google Scholar : PubMed/NCBI
24	Kang YJ: The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med. 222:263–273. 1999. View Article : Google Scholar : PubMed/NCBI
25	Nath R, Kumar D, Li T and Singal PK: Metallothioneins, oxidative stress and the cardiovascular system. Toxicology. 155:17–26. 2000. View Article : Google Scholar : PubMed/NCBI
26	Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F and Pepe SP: Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol. 57:300–309. 2011. View Article : Google Scholar : PubMed/NCBI
27	Jung F, Palmer LA, Zhou N and Johns RA: Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res. 86:319–325. 2000. View Article : Google Scholar : PubMed/NCBI
28	Rus A, del Moral ML, Molina F and Peinado MA: Does inducible NOS have a protective role against hypoxia/reoxygenation injury in rat heart ? Cardiovasc Pathol. 20:e17–e25. 2011. View Article : Google Scholar : PubMed/NCBI
29	Miguel-Carrasco JL, Zambrano S, Blanca AJ, et al: Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond). 7:212010. View Article : Google Scholar : PubMed/NCBI
30	Katragadda S and Arora RR: Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects. Am J Ther. 17:e11–e23. 2010. View Article : Google Scholar : PubMed/NCBI
31	Chan EC, Dusting GJ, Guo N, et al: Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation. J Mol Cell Cardiol. 49:176–185. 2010. View Article : Google Scholar : PubMed/NCBI
32	Maulik N, Engelman RM, Rousou JA, Flack JE III, Deaton D and Das DK: Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation. 100(19 Suppl): II369–II375. 1999. View Article : Google Scholar : PubMed/NCBI
33	Wu S, Storey JM and Storey KB: Phosphoglycerate kinase 1 expression responds to freezing, anoxia, and dehydration stresses in the freeze tolerant wood frog, Rana sylvatica. J Exp Zool A Ecol Genet Physiol. 311:57–67. 2009. View Article : Google Scholar : PubMed/NCBI
34	Jiang XC, Tall AR, Qin S, et al: Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem. 277:31850–31856. 2002. View Article : Google Scholar
35	Cavusoglu E, Marmur JD, Chhabraa S, Choprab V, Eng C and Jiangc XC: Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography. Atherosclerosis. 207:261–265. 2009. View Article : Google Scholar